Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
| Status: | Completed | 
|---|---|
| Conditions: | Cosmetic | 
| Therapuetic Areas: | Dermatology / Plastic Surgery | 
| Healthy: | No | 
| Age Range: | 25 - 70 | 
| Updated: | 4/21/2016 | 
| Start Date: | March 2013 | 
| End Date: | June 2013 | 
The purpose of this study is to characterize rosacea patients', being treated with Oracea,
perception through visual analog scale reporting.
			perception through visual analog scale reporting.
Inclusion Criteria:
- Men and women
- 25-70 years
- Diagnosis of papulopustular rosacea
- Eligible for Oracea treatment
Exclusion Criteria:
- Allergies to components of investigational product and/or hypersensitivity to
tetracyclines
- Taken systemic therapy directed at improving rosacea, including antibiotics, within
30 days prior to baseline visit
- Used topical rosacea treatment within 30 days prior to baseline visit
- Have active ocular rosacea and/or blepharitis/meibomianitis requiring systemic
treatment by an opthalmologist
- Previously failed to have improvement of rosacea with appropriate use of systemic
tetracycline family of antibiotics
- Exposed to intense/excessive ultraviolet (UV) radiation within one week prior to
baseline and/or who forsee unprotected and intense/excessive UV exposure during the
course of the study
- Have planned surgical procedures during the course of the study
- Have used tetracycline antibiotics within 30 days prior to baseline visit or during
study
- At risk in terms of precautions, warnings, and contraindications
We found this trial at
    1
    site
	Click here to add this to my saved trials